Staffing issues are top of mind among leadership at clinical research organizations around the world. Look no further than the ongoing bidding war for monitors/CRAs at sponsors and CROs for proof that top-quality clinical trials staff are a hot commodity. Building a high-quality staff at any clinical research organization – be it a sponsor, CRO, […]
Too many green principal investigators (PIs) blithely sign the U.S. Food and Drug Administration (FDA)-demanded Statement of Investigator (Form 1572) and run the risk of falling into serious trial deviations or even potential legal issues, warns Randall Stoltz, medical director with the Covance Clinical Research Unit in Evansville, Ind. “You have to ask what you […]
Comments submitted regarding Guideline for good clinical practice E6(R2). (Identifier:EMA/CHMP/ICH/135/1995). Click here to read the comments and impact on ACRP Members.
Comments submitted regarding FDA & OHRP joint draft guidance Minutes of Institutional Review Board (IRB) Meetings: Guidance for Institutions and IRBs. (Docket number: FDA-2015-D-3638). Click here to read the comments and impact on ACRP Members.
FOR IMMEDIATE RELEASE: February 2, 2016 CONTACT: Jeremy Glunt + 1.703.258.3506 firstname.lastname@example.org
Research Professionals and the Public to Honor Study Volunteers Who Give the Gift of Participation in Clinical Research
Washington, DC and Boston, MA – The Association of Clinical Research Professionals (ACRP) and the Center for Information and Study on Clinical Research Participation (CISCRP), two […]